Richard A.Gonzalez will retire as chairman of the board and chief executive officer of AbbVie.
According to USA NEWS BREAKING AbbVie said Tuesday that longtime executive Robert Michel will be the company's new CEO, replacing Richard Gonzalez.
Robert A. Michael, who is AbbVie's president and chief operating officer, will become the company's second CEO after leaving Abbott Laboratories in 2013.
Robert A. Michael, who is AbbVie's president and chief operating officer, will become the company's second CEO effective July 1, 2024.
Richard A. Gonzalez is a prominent figure in the pharmaceutical industry, known for his leadership and contributions to healthcare. Born in 1954, Gonzalez earned his Bachelor of Science degree in pharmacy from the University of Houston and later completed an advanced management program at Harvard Business School.
Gonzalez's career spans over four decades, primarily within the pharmaceutical sector. He joined Abbott Laboratories, now AbbVie, in 1977, where he held various roles of increasing responsibility. His tenure at Abbott included positions in research and development, operations, and international management.
In 2007, Gonzalez became President and Chief Operating Officer of Abbott, playing a pivotal role in shaping the company's strategic direction and global expansion. Under his leadership, Abbott experienced significant growth and success in developing innovative healthcare solutions.
Following the spin-off of AbbVie from Abbott in 2013, Gonzalez assumed the role of Chairman of the Board and Chief Executive Officer of AbbVie. During his tenure, AbbVie achieved remarkable milestones, including the successful launch and commercialization of blockbuster drugs such as Humira, a leading treatment for autoimmune diseases.
Gonzalez is widely recognized for his commitment to advancing patient care and driving innovation in the pharmaceutical industry. He has championed initiatives to improve access to healthcare, enhance research and development capabilities, and foster a culture of diversity and inclusion within AbbVie.
Beyond his corporate responsibilities, Gonzalez serves on various advisory boards and committees dedicated to healthcare and business leadership. He has been recognized for his achievements with numerous awards and honors, including being named among the "World's Best CEOs" by Barron's magazine.